Takeda Pharmaceutical agrees to acquire IDM Pharma (IDMI), a developer of anti-cancer...May 18, 2009 6:56 AM ETIDM Pharma, Inc. (IDMI) StockIDMIBy: Eli Hoffmann, SA News Editor Takeda Pharmaceutical agrees to acquire IDM Pharma (IDMI), a developer of anti-cancer treatments, for $2.64/share in an all-cash tender offer followed by a merger. Shares of IDM +19% premarket to $2.02. Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgIDMI--IDM Pharma, Inc.Trending AnalysisTrending News